1st International Workshop on HIV & Aging 4-5 October 2010, Baltimore, MD, USA (click here for details)   Linkage To Care Grant Funds Available from Tibotec - Deadline Sept 30 2010 2010 - 2011 Tibotec Therapeutics LINCC Initiative: Linking In-Need Communities to Care click here for details   Tibotec Therapeutics Debuts Innovative Web Portal for HIV/AIDS Front-Line Service Providers Free, Centralized Resource Designed to Help Overcome Some Barriers to Supportive Care click here for details   Ryan White Care Act Hepatitis C & B Language (click here for details)   Here is a booklet out of the UK from Mike Youle's group on Aging with helpful information on aging with or without HIV. (click here for details)   Current HIV Articles and News Updates     HIV     IAC: Vienna Intl AIDS Conference Thoughts from Jules Levin, NATAP   Is It Safe to Discontinue Primary Pneumocystis jiroveci Pneumonia Prophylaxis in Patients with Virologically Suppressed HIV Infection and a CD4 Cell Count <200 Cells/µL? - (08/30/10)   High Rates of Asymptomatic Neurocognitive Impairment in Vertically Acquired HIV-1-Infected Adolescents Surviving to Adulthood - (08/29/10)   High prevalence of reduced bone mineral density in primary HIV-1-infected men - (08/29/10)   CD4 Predicts acute renal failure: Immunodeficiency and renal impairment are risk factors for HIV-associated acute renal failure - (08/29/10)   Raltegravir Versus Efavirenz Regimens in Treatment-Naive HIV-1-Infected Patients: 96-Week Efficacy, Durability, Subgroup, Safety, and Metabolic Analyses - (08/29/10)   Opioid Use & Bone Loss: Prospective study of bone mineral density changes in aging men with or at risk for HIV infection - (08/29/10)   IAC: Webcast Complications Plenary at IAC Vienna: The Double-Edged Sword: Long-Term Complications of ART and HIV - (08/29/10)   More HIV Articles...         News Updates     Hepatitis C liver deaths warning in UK - (08/30/10)   Economy Makes European Cardiologists Think Twice - pressured on treatment costs - (08/30/10)   HIV/Aging & Muscle Loss/Exercise/ Vit D/GSK - Doctors Seek Way to Treat Muscle Loss (see 2nd article below & links) - NY Times - (08/30/10)   More News Updates Articles...     Current Hepatitis C and B Articles     Hepatitis C     EASL: From Ash To Cure - EASL April 14-18 2010   Outcome of sustained virological responders with histologically advanced chronic hepatitis C (Early HCV Therapy?) - (08/29/10)   HCV Survival in Syringes - The Beginning of a New Era in Understanding Hepatitis C Virus Prevention - EDITORIAL COMMENTARY - (08/25/10)   Survival of Hepatitis C Virus in Syringes: Implication for Transmission among Injection Drug Users - published pdf attached - (08/25/10)   Pharmasset Initiates Phase 2b Clinical Trial of PSI-7977 for Chronic Hepatitis C Genotypes 1, 2, and 3 - (08/25/10)   ZymoGenetics Announces Completion of Enrollment in Phase 2b Clinical Trial with PEG-Interferon lambda in Hepatitis C - (08/25/10)   Common variation of IL28 affects gamma-GTP levels and inflammation of the liver in chronically infected hepatitis C virus patients - (08/25/10)   More Hep C Articles...         Hepatitis B     Tenofovir and Entecavir Are the Most Effective Antiviral Agents for Chronic Hepatitis B: A Systematic Review and Bayesian Meta-Analyses - pdf published attached - (08/25/10)   HBV Drug Therapy: Tenofovir....IFN, Entecavir publication pdf attached - (08/11/10)   Long-term entecavir therapy results in reversal of fibrosis/cirrhosis and continued histologic improvement in chronic hepatitis B patients - publication pdf attached - (08/11/10)   More Hep B Articles...   Check Out Our Special NATAP Features   HEP DART 2009 December 06-10, 2009 Kohala Coast, HI USA http://www.informedhorizons.com/hepdart2009   International Symposium on HIV and Emerging Infectious Diseases Marseille, France 24 to 26 March 2010 www.isheid.com   Digestive Disease Week DDW 2009 May 30 - June 4, 2009 McCormick Place: Chicago, Illinois www.ddw.org/   IAS 2009 - Cape Town - International AIDS Society 5th IAS Conference on HIV Pathogenesis, treatment and Prevention 19-22 July 2009 Capetown, South Africa www.ias2009.org/   49th ICAAC San Francisco, CA September 12-15, 2009   6th International Symposium on Hepatitis C Virus and Related Viruses October 3-7 Nice, France www.hcv2009.org/   11th International Workshop on Adverse Drug Reactions & Co-Morbidities in HIV October 26-28 2009 Philadelphia, PA www.intmedpress.com/lipodystrophy/   AASLD Liver Meeting Boston, MA, Hynes Convention Center October 30-November 3, 2009   EACS - 12th European AIDS Conference November 11-14, 2009 Cologne, Germany   13th International Symposium on Viral Hepatitis and Liver Disease 15000 Commerce Parkway, Suite C Mount Laurel, NJ 08054 www.isvhld2009.org/   XVIII International HIV Drug Resistance Workshop http://www.informedhorizons.com/resistance2009/index.html June 9-13, 2009 Fort Myers, Florida USA   HEP DART 2009: Frontiers in Viral Hepatitis http://hepdart.com December 6-10, 2009 Kohala Coast, Big Island, Hawaii USA   Fourth International Workshop on HIV Persistence during Therapy http://informedhorizons.com/persistence2009/index.html December 8-11, 2009 St. Martin, West Indies   Virology Education Workshops   7th European HIV Drug Resistance workshop 25-27 March 2009, Stockholm, Sweden   10th International Workshop on Clinical Pharmacology of HIV Therapy 15-17 April 2009 - Amsterdam, The Netherlands   5th International HIV and Hepatitis Co-infection workshop 4-6 June 2009 - Lisbon, Portugal   4th International Workshop on Hepatitis C, resistance and New Compounds 25-26 June 2009, Boston, MA USA_Venue: Sheraton Boston Hotel   4th International Workshop on HIV Transmission-Principles of Intervention 16-18 July 2009, Cape Town, South Africa   The International Symposium on Viral Hepatitis and Liver Disease (ISVHLD)   IAS Conference on HIV Pathogenesis, Treatment and Prevention   International Workshop on Hepatitis C, Resistance and New Compounds   International Workshop on Clinical Pharmacology of Hepatitis Therapy   ICAAC - Interscience Conference On Antimicrobial Agents & Chemotherapy (ICAAC)   International Symposium on Hepatitis C and Related Viruses   Infectious Diseases Society of America (IDSA)   Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)   International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV   European Conference on Clinical Aspects and Treatment of HIV-Infection (EACS)   Association Of Nurses In AIDS Care (ANAC)   International Workshop Targeting HIV Entry   National Viral Hepatitis Prevention Conference   International HIV and Hepatitis Co-infection Workshop   European HIV Drug Resistance Workshop   International Workshop on Clinical Pharmacology of HIV Therapy   International HIV Drug Resistance Workshop   International AIDS Conference   International Workshop on Clinical Pharmacology of HIV Therapy   International Workshop on Clinical Pharmacology of Hepatitis Therapy   Annual Meeting of the European Association for the Study of the Liver (EASL)   Digestive Disease Week   International HIV Drug Resistance Workshop   AIDS 2010 18th International AIDS Conference (IAC) July 18-23 2010 Vienna, Austria   5th International Workshop on Hepatitis C Resistance and New Compounds Boston, MA June 24-25, 2010   The 5th International Workshop on Clinical Pharmacology of Hepatitis Therapy Boston, MA June 23-24, 2010   International HIV and Hepatitis Drug Resistance Workshop June 8-12, 2010 Dubrovnik Croatia   Microbicides Conference May 22-25, 2010 Pittsburgh, Pennsylvania   EASL 45th Annual Meeting (European Association for the Study of the Liver) April 14-18, 2010 Vienna, Austria   11th International Workshop on Clinical Pharmacology and HIV Therapy April 7-9, 2010 Sorrento, Italy   Conference of the Asian Pacific Association for the Study of the Liver 2010 20th APASL March 2010 Beijing, China   17th CROI Conference on Retroviruses and Opportunistic Infections San Francisco, CA Feb 16-19, 2010   HEP DART 2009 December 06-10, 2009 Kohala Coast, HI USA   EACS - 12th European AIDS Conference November 11-14, 2009 Cologne, Germany   AASLD 60th Annual Meeting of the American Association for the Study of Liver Diseases Boston, MA USA October 30 - November 3 2009   Infectious Disease Societyof America (IDSA) 47th Annual Meeting Philadelphia, USA October 29 - November 1, 2009   11th Workshop on Adverse Drug Reactions and Co-morbidities in HIV Philadelphia, USA Oct 26-28 2009   49th ICAAC San Francisco, CA September 12-15, 2009   5th IAS Conference on HIV Pathogenesis, Treatment and Prevention 19-22 July 2009 Capetown, South Africa   The 4th International Workshop on Clinical Pharmacology of Hepatitis Therapy Boston, MA June 27, 2009   4th International Workshop on Hepatitis C Resistance and New Compounds 25-26 June 2009, Boston, MA USA   18th HIV Drug Resistance Workshop June 9-12 2009 Ft Myers Florida   DDW 2009 May 30 - June 4, 2009 McCormick Place: Chicago, Illinois   EASL 44th Annual Meeting (European Association for the Study of the Liver) April 22-26, 2009 Copenhagen, Denmark   10th International Workshop on Clinical Pharmacology of HIV Therapy April 15-17, 2009 Amsterdam   7th European HIV Drug Resistance Workshop March 25-27, 2009 Stockholm   13th International Symposium on Viral Hepatitis and Liver Disease March 20th - 24th 2009 Washington, DC   19th APASL- Conference of the Asian Pacific Association for the Study of the Liver 2009 Feb 2009 Hong Kong   16th CROI Conference on Retroviruses and Opportunistic February 8-11, 2009 Montreal, Canada   View More Conference Reports...   La informacion Que Necesitas Sobre el VIH - 06/15/10 New Goals and New Drugs for People With Heavy Anti-HIV Drug Experience - 06/05/07 Do you have HIV/HCV Coinfection? - 11/28/06 HIV 101 : The Basics - 11/28/06 VIH 101 : Lo Basico - in Spanish - 11/28/06 HIV 102 : Care and Treatment of HIV - 11/28/06 VIH 102 : Cuidado Y Tratamiento del VIH - in Spanish - 11/28/06 Hepatitis C and Hepatitis C Co-Infection Handbook PDF Version V 11/08/05 Download More NATAP Publications... Support provided by: Abbott, Boehringer-Ingelheim, Bristol-Myers Squibb, Gilead, GlaxoSmithKline, Merck, Roche, Schering-Plough, Tibotec, Vertex   Patient Assistance Programs for HCV Therapy from the Drug Manufacturers: Pegylated Interferon and ribavirin If you cannot get reimbursement or coverage for pegylated interferon and ribavirin the manufacturers of pegylated interferon have reimbursement programs which supply free drugs if you qualify. These programs will first help you try to identify sources for reimbursement.   Schering makes Peg-Intron and ribavirin (Rebetol): Call 1-800-521-7157. Roche makes Pegasys and ribavirin (Copegus): 1-800-387-1258.